Preparations for Phase 1/2 clinical trial in Australia utilizing fibroblast-based spheroids product candidate, CYWC628, to treat diabetic foot ulcers are proceeding with plans to initiate in the third ...

FibroBiologics, Inc. (Nasdaq: FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 240+ patents issued and pending for the development of therapeutics ...

In a new study published in Nature, researchers at the University of Chicago Medicine Comprehensive Cancer Center explore a ...

Operator: Ladies and gentlemen, thank you for standing by, and welcome. At this time all participants are in listen-only mode ...

Tissues consist of a heterogeneous mixture of different cell types, complicating our understanding of their biological ...

Using a new fluorescent mouse model with advanced imaging techniques, researchers have successfully visualized how musculoskeletal components are integrated into the functional locomotor system during ...

Although not designed to eliminate experiments, the model, which is intended to accelerate process development, can reduce the number needed.

Pompeu Fabra University (UPF) and the Royal Veterinary College of London have worked together on a pioneering project ...

The scientists at the University of California, San Francisco and Johns Hopkins University in Baltimore injected an antisense ...